A new five-year study of chronic kidney disease in children will draw on University of Florida informatics expertise to investigate how medication and blood pressure monitoring can improve outcomes.
A successful communication skills training program about clinical trials is expanding to cover pediatric cancer. The workshop trains medical oncology fellows to communicate clearly with patients and their families about the benefits of enrolling in a clinical trial.
Dr. Elizabeth “Betsy” Shenkman, Ph.D., has earned the highest honor for a faculty member at the University of Florida: Distinguished Professor. This rare designation denotes the perseverance necessary to reach extraordinary academic achievement and influence.
Yi Guo, Ph.D., is a collaborator on new research that has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease.
A mother-daughter story of a painful, misunderstood disease is turning into a teachable moment.
McKnight Brain Institute: The project of Yonghui Wu, Ph.D., and Rui Yin, Ph.D., aims to develop innovative computational tools and analytical frameworks to better understand why some Alzheimer’s patients progress rapidly and others slowly, to improve future clinical trial design and interventions.
An undergraduate could get lost in the graduate student atmosphere on the top floor of Malachowsky Hall for Data Science and Information Technology, but that’s not the case for senior Harold Bishop. He has leapfrogged with ease into the mature world of graduate-level research and steady employment.
Todd Manini, Ph.D., is one of four faculty members in the College of Medicine to be named a 2026 UF Research Foundation Professor.
“We play a key role in responding to the cancer plan in the state of Florida, especially given the disproportionate burden in our region.” — Ramzi Salloum, Ph.D.
Nine UF Health Cancer Institute researchers have been awarded pilot funding for innovative cancer research projects that aim to advance our understanding of how cancer develops and resists treatment, as well develop novel strategies for preventing cancer and personalizing treatment.
